Contact

location_on

6 rue Dr Jean-François-Xavier Girod
25000 Besançon
France

Etienne Thibault
Représentant commercial

About us

Diaclone, part of Medix Biochemica, is a major player in the development of monoclonal antibodies and immunoassays for over 35 years.

 

Our experience and expertise coupled to the diversity and quality of our products and services makes Diaclone a clear choice to fast track your research. Diaclone offers solutions for custom development and production of antibodies from µg to kg and immunoassays.

 

Diaclone is a CRO/CDMO specialising in immunotechnologies. ISO 9001:2015 certified and CIR (Crédit Impôt Recherche) accredited.

Business offer

The expanding range of our immunology products is specifically designed to advance research, preclinical and diagnostic applications in the fields of immunotherapy and cancer, inflammation, allergy, autoimmune diseases, amongst others.

 

- Diaclone antibodies are murine monoclonal antibodies specific for the detection of mainly human proteins. These antibodies can be used in a wide range of applications including ELISA, ELISpot, flow cytometry, western blotting, immunohistochemistry, immunoprecipitation, and bioassays.

 

- Diaclone ELISA kits are highly sensitive tests designed for the in vitro quantitative determination of natural and recombinant proteins from serum, plasma, culture supernatant and biological fluid.

 

- Diaclone ELISpots kits are highly specific immunoassays for the analysis of the production and secretion of cytokines and other soluble molecules from T lymphocytes at the level of a single cell in conditions close to the in vivo environment with minimal cell manipulation.

 

- A service platform for the custom development of monoclonal antibodies derived from hybridomas or recombinants, for their characterisation, controls and the development of immunoassays.

  • •    Development of murine monoclonal antibodies (hybridoma technology): technical expertise for over 35 years, with a personalised service and a wide choice of screening methods, depending on the applications targeted.
  • •    Generation of recombinant antibodies (Fab, ScFv) using Phage display technology (mouse, llama, chicken and rabbit in development).
  • •    Analytical services: quality controls, specificity tests, sensitivity tests, bioactivity tests, etc.
  • •    Bioassay platform (antibody binding and kinetics, ADCC, ADCP…).

Activities

    Categories

    • Service

    Therapeutic applications

    • Genetic Diseases
    • Oncology
    • Immunology
    • Inflammation

    Expertises

    Directory of Antibodies, Recombinant proteins and others
    • Hit discovery
    • Screening & Identification
    • In-vitro & ex-vivo models
    • Immunotherapy lead generation
    • Binding & Affinity
    • Potency & Specificity
    • Functional effects
    • ADCC, ADCP & CDC
    • Antigen density target
    • Cell activation
    • Antibody-based activation
    • Immunotherapy lead optimization
    • Engineering
    • Fragments
    • Affinity maturation
    • Bioproduction
    • Batches production type
    • Mammalian
    • Bacterial
    • Quality assurance, quality control & analytical process
    • Stability Assessment
    • pH
    • Freeze/thaw
    • Heat/degradation
    • Aggregation
    • Cell line analytical development
    • Contaminants detection
    • Biosafety & Bioanalysis
    • Impurities detection
    • Bioproduction analytical test
    • Characterization
    • Batch consistency
    • Batch release test
    • Chemical, physical, biological test
Français English